設計及合成具有四位及六位取代的嘧啶核苷作為具有潛力的ODCase抑制劑

Design and Synthesis of 4- or 6-Substituted Pyrimidine Nucleosides as Potential Inhibitors for Orotidine 5'-Monophosphate Decarboxylase

史諭樵(Yu-Chiao Shih)

指導教授 ： 簡敦誠

國立臺灣師範大學/理學院/化學系/碩士(2008年)

摘要

摘要
本論文針對 orotidine 5’-monophosphate decarboxylase (ODCase) 設計 6-aryluridine 衍生物，希望合成出對 ODCase 具有生物活性的化合物，並作為可能的 ODCase 抑制劑。
首先，期望利用 C-C 鍵的生成，得到 6-aryluridine 衍生物。我們使用文獻方法，合成 6-halouridine 衍生物，再進行 Suzuki coupling 及 Stille coupling 反應，但實驗結果未能得到預期的產物。
接者，我們改用 click chemistry 來合成 6-aryluridine 衍生物。以 1,3-dimethyl-6-chlorouracil 與 NaN3 進行親核性取代反應得到 6-azido-1,3-dimethyluracil ，再與 acetylene 進行 Huisgen 1,3-dipolar 環化加成反應，得到具有 1,2,3-triazole 取代的 uracil 衍生物。
另外，希望以相同的方法合成出具有 1,2,3-triazole 的 uridine 衍生物。以醣已保護的 uridine 衍生物作為反應起始物，與 LDA 作用，再與 iodine 反應得到 6-iodouridine 衍生物，再利用模型反應的條件可以得到預期的 6-(1,2,3-triazolyl)uridine 衍生物。後續利用三氟醋酸去除 tert-butyldimethylsilyl 及 isopropylidene 保護，由於產物的不穩定，未能得到預期的 triazolyluridine 產物。在本論文中，我們成功地利用 click chemistry 製備 6-(1,2,3-triazolyl)uridine 衍生物，醣的去保護方法仍需要再深入研究。

關鍵字

ODCase

並列摘要

Abstract
We have designed 6-aryluridine derivatives targeting on orotidine 5’-monophosphate decarboxylase (ODCase) as potential inhibitors and chemotherapeutic agents.
We anticipated to utilize C-C bond formation approach to introduce the 6-aryl substituent on uridine. 6-Halouridine derivatives were prepared by literature procedures. However, both Suzuki coupling and Stille coupling reaction failed to afford the desired 6-aryluridine derivatives.
We then utilized click chemistry to prepare 6-aryluridine derivatives. 1,3-Dimethyl-6-chlorouracil was treated with sodium azide to give 6-azido-1,3-dimethyluracil by nucleophilic substitution reaction. Huisgen 1,3-dipolar cycloaddition reaction of the azidouracil with acetylene in the presence of Cu(I) catalyst afforded 1,2,3-triazole substituted uracil in good yield.
The same approach was applied to the synthesis of 1,2,3-triazole substituted uridine derivatives. The suger-protected uridine derivative was used as a starting material and was treated with lithium diisopropylamide, and then was reacted with iodine to give the corresponding 6-iodouridine derivative. The azido group was introduced by nucleophilic substitution reaction. The 6-azidouridine derivative underwent 1,3-dipolar cycloqddition to afford the corresponding 1,2,3-triazole. The removal of tert-butyldimethylsilyl and isopropylidene group with trifluoroacetic acid was unsuccessful to give the desired product. We have successfully prepared 6-(1,2,3-triazolyl)uridine derivative. The deprotection of suger moiety needs further investigation.

參考文獻

1. Wu, W.; Ley-han, A.; Wong, F. M.; Austin, T. J.; and Millert S. M. Decarboxylation of 1,3-dimethylorotic acid revisited: determining the role of N-l . Bioorg. Med. Chem. Lett. 1997, 7, 2623-2628.

2. Nakanishi, M. P.; and Wu, W. Mechanism of decarboxylation of l,3-dimethylorotic acid revisited: trapping of the reaction intermediate. Tetrahedron Lett. 1998, 39, 6271-6272.

3. Cui, W.; DeWitt, J. G.; Miller, S. M.; and Wu, W. No metal cofactor in orotidine 5’-monophosphate decarboxylase. Biochem. and Biophy. Res. Commun. 1999, 259, 133–135.

4. Feng, W. Y.; Austin, T. J.; Chew, F.; Gronert, S.; and Wu, W. The mechanism of orotidine 5’-monophosphate decarboxylase: catalysis by destabilization of the substrate. Biochemistry 2000, 39, 1778-1783.

5. Bello, A. M.; Poduch, E.; Fujihashi, M.; Amani, M.; Li, Y.; Crandall, I.; Hui, R.; Lee, P. I.; Kain, K. C.; Pai, E. F.; and Kotra, L. P. A potent, covalent inhibitor of orotidine 5’-monophosphate decarboxylase with antimalarial activity. J. Med. Chem. 2007, 50, 915-921.